From Casetext: Smarter Legal Research

In re Cellcyte Genetic Corp. Securities Litigation

United States District Court, W.D. Washington, at Seattle
Nov 20, 2008
Case No. C08-47RSL (W.D. Wash. Nov. 20, 2008)

Opinion

Case No. C08-47RSL.

November 20, 2008


ORDER GRANTING MOTION TO DISQUALIFY LANE POWELL PC


I. INTRODUCTION

This matter comes before the Court on a motion filed by defendant Dr. Ronald Berninger to disqualify Lane Powell PC ("Lane Powell"), counsel for defendant G. Brent Pierce. Dr. Berninger argues that Lane Powell should be disqualified from representing Pierce because the firm also represents two other clients involved in this litigation and in three related matters. Two other defendants, CellCyte Genetics Corporation and Gary Reys, have joined in Dr. Berninger's motion.

II. ANALYSIS

In January 2005, defendants Dr. Ron Berninger and Gary Reys co-founded CellCyte Washington, a private company dedicated to human stem cell research and development of stem cell therapies. After a reverse merger, CellCyte Genetics Corporation was formed in February 2007.

Lane Powell represents Brent Pierce, a defendant in this case accused by investors of engineering a "pump and dump" scheme to artificially inflate the price of CellCyte's stock. Plaintiffs allege that Pierce has a history of engaging in similar schemes.

Lane Powell also represents Leonard Braumberger, a long-time associate of Pierce who worked as a consultant for CellCyte. In addition, Lane Powell represents Dr. Theresa Deisher, the former Vice President of Research and Development for CellCyte. In that role, she participated in research and in presentations to encourage investment in CellCyte. She has filed a civil lawsuit against CellCyte, Dr. Berninger, and others alleging claims arising out of her employment with CellCyte. Specifically, she alleges that CellCyte, Dr. Berninger and Reys induced her to take the job based on false information, and she became a whistle blower once she learned the truth. Dr. Deisher does not allege that Pierce or Braumberger engaged in fraud.

The SEC has issued a formal order of investigation relating to CellCyte. Pierce, Braumberger, and Dr. Deisher have all testified before the SEC. The SEC is also investigating Pierce's role. The U.S. Attorney's Office for the Western District of Washington has opened a federal criminal investigation involving CellCyte, and Pierce is a target of that investigation. Dr. Deisher is not a defendant in this case. Nor is she a target of the investigations by the SEC or the U.S. Attorney's Office.

All three clients have consulted with independent counsel. All three have stated that after those consultations, they want Lane Powell to continue to represent them.

A. Standing.

Lane Powell argues that Dr. Berninger lacks standing to move to disqualify the firm. It contends that only a current or former client has standing to challenge an attorney's representation of another party. As a court in this district recently noted, "[N]either the United States Supreme Court nor the Ninth Circuit has addressed the particular question of whether the standing doctrine bars a nonclient party from moving to disqualify the opposing party's counsel on the grounds of a conflict of interest." FMC Technologies, Inc. v. Edwards, 420 F. Supp.2d 1153, 1156 (W.D. Wash. 2006) (considering plaintiff's motion to disqualify defense counsel). The court in FMC Technologies noted that courts may consider non-client initiated disqualification challenges based on the courts' "inherent power to `protect the integrity of their processes.'" Id. at 1156 (quoting Colyer v. Smith, 50 F. Supp.2d 966, 970 (C.D. Cal. 1999) (describing the "`court's well recognized power to control the conduct of the attorneys practicing before it'" and to ensure the fair administration of justice); see also Trone v. Smith, 621 F.2d 994, 999 (9th Cir. 1980) (stating, in the disqualification context, "The primary responsibility for controlling the conduct of lawyers practicing before the district court rests with that court.").

In this case, because the motion has merit, as discussed below, the Court has a "`plain duty to act.'" FMC Technologies, 420 F. Supp.2d at 1157 (quoting In re Yarn Processing Patent Validity Litig., 530 F.2d 83, 89 (5th Cir. 1976)). It must act to protect the integrity of the process and to protect the litigants. Accordingly, the Court considers Dr. Berninger's motion to disqualify Lane Powell.

B. Conflict of Interest.

The Court considers the possibility that Dr. Berninger has brought this motion as a litigation tactic. Lane Powell argues that the timing of the motion supports that view. However, Dr. Berninger's current counsel raised the conflict issue with Lane Powell within a week after making their appearance. Previous counsel had also raised the issue with Lane Powell. The evidence does not support a finding that this motion is a tactic.

Attorneys practicing before this Court must comply with the Washington Rules of Professional Conduct. General Local Rule 2(e)(2). This matter is governed by Washington Rule of Professional Conduct 1.7, which addresses conflicts of interest involving representation of current clients. Rule 1.7 provides as follows:

(a) Except as provided in paragraph (b), a lawyer shall not represent a client if the representation involves a concurrent conflict of interest. A concurrent conflict of interest exists if:

(1) the representation of one client will be directly adverse to another client; or

(2) there is a significant risk that the representation of one or more clients will be materially limited by the lawyer's responsibilities to another client, a former client or a third person or by a personal interest of the lawyer.

(b) Notwithstanding the existence of a concurrent conflict of interest under paragraph (a), a lawyer may represent a client if:

(1) the lawyer reasonably believes that the lawyer will be able to provide competent and diligent representation to each affected client;

(2) the representation is not prohibited by law;

(3) the representation does not involve the assertion of a claim by one client against another client represented by the lawyer in the same litigation or other proceeding before a tribunal; and

(4) each affected client gives informed consent, confirmed in writing (following authorization from the other client to make any required disclosures).

RPC 1.7(a)(2) permits an attorney to continue to represent conflicted current clients if "the lawyer reasonably believes that the lawyer will be able to provide competent and diligent representation to each affected client." The "reasonableness" issue includes an objection and subjective component. RPC 1.0(h) (i).

Lane Powell argues that there is no conflict of interest, but even if one exists, it is waivable. Waivability will turn on whether the Lane Powell attorneys reasonably believe that they can provide competent and diligent representation to all three of their clients simultaneously. For purposes of resolving this motion, the Court will not delve into the minutiae of who said what to whom at which meeting. The merits of the various disputes cannot be resolved in this motion. Rather, the Court will focus on the realities of the representation.

Lane Powell contends that no conflict exists, in part because none of its clients is asserting a claim against another client. That factor weighs in favor of finding that the clients' interests are not directly adverse. However, the clients' interests may become directly adverse in the likely event that Lane Powell is required to cross examine its own clients. At the least, Lane Powell's representation of one client will materially limit its representation of another client. Although Dr. Deisher is not a party in this proceeding, she, like Braumberger, is likely to be a witness. Similarly, Pierce and Braumberger are likely witnesses in Dr. Deisher's arbitration. For that reason, Lane Powell will be required to cross examine its own clients in both proceedings. Dr. Deisher has an interest in proving fraud, which, according to plaintiffs in this case, directly involved Pierce and Braumberger. Their role in the alleged fraud is hotly contested. The Court cannot assume that plaintiffs' allegations are baseless and that the SEC and criminal investigations involving Pierce (and potentially Braumberger) lack merit. Therefore, as the facts emerge, there is a probability that Dr. Deisher's interests and those of Pierce and Braumberger could become adverse. See ABA Formal Opinion 92-367 (explaining that direct adverseness occurred when an attorney had to cross examine a client in an unrelated matter); see also Declaration of Arthur Lachman, (Dkt. #110) ("Lachman Decl.") at ¶ 31 ("Based on the facts as they develop in the pending litigation matters, at some point in the future a direct adversity conflict of interest may arise if [Lane Powell] lawyers determine that they must cross-examine one of their clients in the course of representing one of the others").

The purpose of the rule against concurrent representation is based "on the duty of undivided loyalty an attorney owes a client." Smiley v. Office of Workers Compensation Programs, 984 F.2d 278, 282 (9th Cir. 1993) (explaining that among other things, the rule was designed to prevent "an honest practitioner from having to choose between conflicting duties, or attempting to reconcile conflicting interests rather than enforcing a client's rights to the fullest extent"). As the ABA opinion explained, "an attorney should not be permitted to put himself in a position where, even unconsciously, he will be tempted to `soft pedal' his zeal in furthering the interests of one client to avoid an obvious clash with those of another." ABA Formal Opinion 92-367 at p. 3. In this case, there would be an obvious temptation for Lane Powell to "soft pedal" its cross examination of its own clients to further the interest of other clients, or its own interest in continuing the multiple representation. The conflict is even more apparent than in the ABA opinion because the matters are related.

Lane Powell and its expert contend that the conflict can be mitigated by bringing in substitute counsel to cross examine its clients if necessary. However, once a trial is underway, bringing in other counsel is no simple matter. Doing so would result in significant delay for everyone involved and possibly increase costs for the clients. Moreover, it would be difficult for new counsel to conduct an effective cross examination without being familiar with the entire case. Some of the clients' interests would be undermined by having unfamiliar counsel conduct a cross examination rather than experienced counsel. Moreover, it is difficult to imagine how Lane Powell could advise one client about whether to call another of its clients as a witness without disclosing confidences and while maintaining loyalty to all.

In fact, the firm has an ethical obligation to share all relevant information learned, regardless of the source or the context, with its clients. Comment [31] to RPC 1.7 explains,

[C]ontinued common representation will almost certainly be inadequate if one clients asks the lawyer not to disclose to the other client information relevant to the common representation. This is so because the lawyer has an equal duty of loyalty to each client, and each client has the right to be informed of anything bearing on the representation that might affect that client's interests and the right to expect that the lawyer will use that information to that client's benefit.

The criminal investigations, Dr. Deisher's arbitration, and this case all involve the same transactions and underlying facts. This reality makes it very likely that Lane Powell will learn facts that ethically it should, but cannot, share with its other clients. For example, if Lane Powell learned confidential information from representing Pierce and Braumberger before the SEC, it must share that information with Dr. Deisher if it would help her in her arbitration. It is easy to imagine that in their interviews with the SEC, Pierce and Braumberger disclosed information about their roles in the alleged securities fraud that they would want to keep from others, including Dr. Deisher. The duty to share information and of undivided loyalty undermines Lane Powell's argument that the limited scope of its representation avoids a conflict. Reply Declaration of David Boerner, (Dkt. #124) ("Boerner Reply Decl.") at ¶ 5; Reply Declaration of John Strait, (Dkt. #125) ("Strait Reply Decl.") at p. 3.

Lane Powell argues that there is no conflict because its clients share a common interest: all three want to show that CellCyte engaged in fraud. Even if the clients' interests are aligned now, the Court cannot assume that they will not diverge later. If a deeper conflict arises later in the proceedings, dealing with it will be much more difficult and disruptive later.

Moreover, the perpetuation of a common theory of representation for all three clients is in itself very troubling. It is possible that the duty of loyalty and zealous representation is undermined by Lane Powell's interest in continued representation and/or its loyalty to other clients. Strait Reply Decl. at p. 6 ("Key to Mr. Lachman's declaration and [Lane Powell's] position is the claim that there is no factual inconsistency between the firm's various clients. But that claim itself is the product of the very conflict that requires [Lane Powell's] disqualification"). Even absent any other issues, the Court would find an unwaivable conflict based on the fact that Lane Powell, based on its own interest and the interest of its other clients, could be discouraged from exploring strategies that do not comport with the common theme.

Other issues convince the Court that the conflict is not waivable. Lane Powell essentially concedes that it has an unwaivable conflict of interest in representing its clients in the criminal proceedings. However, its duty of loyalty and to communicate with its clients shows that the same conflict exists regardless of whether the context is criminal or civil. Strait Reply Decl. at p. 5 ("In effect, Lane Powell's duty to communicate with its clients in the matters in which it has not withdrawn generates exactly the same conflicts that would exist if it continued to directly represent these clients in the criminal and SEC investigations in which it concedes it has a non-waivable conflict of interest"). Moreover, the Court must consider whether Lane Powell was able to make the disclosures necessary to obtain informed consent. It may have gained confidential information from one or all three of its clients in the context of this litigation, Dr. Deisher's arbitration, and/or the SEC investigation. If Lane Powell cannot disclose some of the information it learned from one client to the others, then their consent to the representation was not fully informed. Comment [19] to RPC 1.7. For all of these reasons, the Court finds that Lane Powell has a conflict of interest in the concurrent representation that is not waivable.

The Court does not reach this conclusion lightly. Disqualification is a drastic measure. The Court is loathe to interfere with a party's choice of counsel or with the attorney-client relationship. In this case, the matter is further complicated by the numerous proceedings involved, Dr. Deisher's rapidly-approaching arbitration, and the amount of time and money already poured into the various relationships. The Court weighs those factors against its role in protecting the fairness of the proceedings. In the end, the fairness of the proceedings must prevail.

The Court also considered whether a solution less than complete disqualification might be warranted. The parties did not suggest any such remedy, and none seems available.

III. CONCLUSION

For all of the foregoing reasons, the Court GRANTS Dr. Berninger's motion to disqualify Lane Powell (Dkt. #84). From the date this order is posted, Lane Powell is precluded from representing Pierce, Braumberger or Dr. Deisher in this matter. It must advise Pierce to obtain substitute counsel in this case or provide the Court with pro se contact information.


Summaries of

In re Cellcyte Genetic Corp. Securities Litigation

United States District Court, W.D. Washington, at Seattle
Nov 20, 2008
Case No. C08-47RSL (W.D. Wash. Nov. 20, 2008)
Case details for

In re Cellcyte Genetic Corp. Securities Litigation

Case Details

Full title:In re CELLCYTE GENETIC CORPORATION SECURITIES LITIGATION This order…

Court:United States District Court, W.D. Washington, at Seattle

Date published: Nov 20, 2008

Citations

Case No. C08-47RSL (W.D. Wash. Nov. 20, 2008)

Citing Cases

U.S. Fire Ins. Co. v. Icicle Seafoods, Inc.

The Court is not persuaded that Icicle satisfies the standing requirement to move for disqualification of…

Gordon v. Dadante

OHIO RULE OF PROFESSIONAL CONDUCT 1.7. Finally, although courts in this district refer to the Ohio…